National drug regulators use evidence from clinical trials to decide whether new cancer drugs will be approved for use. But these studies are often flawed.
L’expertise universitaire, l’exigence journalistique
Articles sur Regulation
Affichage de 161 à 180 de 416 articles
The failure of regulators to take decisive action against errant companies is an unintended consequence of the design of ‘responsive regulation’.
Newark is the latest US city to struggle with high lead levels in drinking water. Ending this public health crisis will require more money and enforcement, plus stricter water testing standards.
New technologies and services aren’t creating irreversible damage, even though they do generate some harms. Preemptive bans would stifle innovation and block potential solutions to real problems.
Previously secret documents and data make it clear that many companies engaged in the distribution of prescription painkillers either skirted or ignored their legal obligations for years.
For all their good intentions, accidents happen when fallible humans intervene in complex systems they don’t understand.
Bureaucratic ‘red tape’ has contributed to the current crisis in our aged care system. We need a system of accountability that focuses more on residents’ outcomes, and less on processes.
Millions of Americans rely on groundwater for their lives and livelihoods, but regulation is piecemeal. A new study maps groundwater wells nationwide and finds that they are drilling steadily deeper.
Expanding the services offered by pharmacies can have positive effects on health outcomes — and profits.
In order to reach younger audiences, social media apps must get past the gatekeepers of preteen online engagement: the parents.
US lawmakers and regulators are beginning to investigate big tech’s growing power, but they need to look beyond size and into their very natures.
The 6-3 ruling challenges some common political assumptions about conservatives and liberals.
A Nobel Prize-winning political economist found a way to promote good governance and protect users without the need for heavy-handed government regulation.
People know about Facebook’s problems, but assume they are largely immune – even while they imagine that everyone else is very susceptible to influence.
Uber’s IPO will value the company at more than $80 billion, yet the data it collects on its users may be worth even more – and creates the potential for dangerous manipulation.
The ‘thin green line’ of resistance against any new infrastructure for shipping oil, gas and coal abroad has won many battles.
Air quality in the US has improved greatly since 1990, but a new report finds progress stalling in some cities. Meanwhile, the Trump administration is rolling back air pollution controls.
Are health risks from air pollution less serious than we think? Mainstream scientists call this a fringe view, but it’s getting high-level attention at the Environmental Protection Agency.
The Facebook boss’s calls for outside help to draft new rules on what is acceptable behaviour online should be welcomed. So what’s his next step?
Of course people need ethics. But the current troubles in the technology industry are not evidence of an ethics crisis; it is a public-policy crisis.
Les contributeurs les plus fréquents
-
Professor of Law, University of Pittsburgh
-
Professor of Information Systems, Michigan State University
-
Director of Energy Studies, University of Florida
-
Professor of Accounting, The Ohio State University
-
Distinguished Professor of Practice, Trachtenberg School of Public Policy & Public Administration, and Director of the Regulatory Studies Center, George Washington University
-
Senior Lecturer, Faculty of Law, University of Wollongong
-
Glenn E. Futrell Distinguished University Professor of Environmental Engineering, North Carolina State University
-
Senior Lecturer in Economics, Lancaster University Management School, Lancaster University
-
Professor, Monash University
-
-
Emeritus Professor of Accounting, University of Essex, University of Essex
-
Professor of Law, University of California, Davis
-
Vice Chancellor's Fellow at Victoria University and Adjunct Professor of Economics, Victoria University
-
Reader (Associate Professor) in Law, University of East London
-
Conjoint Clinical Associate Professor, Deakin University School of Medicine and Specialist Pain Medicine Physician, Deakin University
